Cargando…
Pitfalls of Unfractionated Heparin Use During ST-Segment Elevation Myocardial Infarction in Patients With COVID-19 Infection
Autores principales: | Martin, Anne-Céline, Godier, Anne, Karam, Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Cardiology Foundation. Published by Elsevier.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781527/ https://www.ncbi.nlm.nih.gov/pubmed/33413932 http://dx.doi.org/10.1016/j.jacc.2020.08.090 |
Ejemplares similares
-
Reply: Pitfalls of Unfractionated Heparin Use During ST-Segment Elevation Myocardial Infarction in Patients With COVID-19 Infection
por: Choudry, Fizzah A., et al.
Publicado: (2021) -
Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous Coronary Intervention
por: Centurión, Osmar Antonio
Publicado: (2016) -
A potential diagnostic pitfall in ST elevation: Acute pulmonary embolism or ST‐segment elevation myocardial infarction
por: Zheng, Bo, et al.
Publicado: (2021) -
Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome
por: Seaman, Craig D., et al.
Publicado: (2020) -
Pandemic‐Related Pollution Decline and ST‐Segment‒Elevation Myocardial Infarctions
por: Aung, Sidney, et al.
Publicado: (2022)